Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg – far below the standard guidelines of 140 mmHg – to reduce the risk of heart disease in ...

The cardiovascular benefits observed with intensive blood pressure (BP) control in patients with hypertension and elevated cardiovascular risk from the Systolic Blood Pressure Intervention Trial ...

In a previously reported randomized trial of standard and intensive systolic blood-pressure control, data on some outcome events had yet to be adjudicated and post-trial follow-up data had not yet ...

Intensive interventions to reduce blood glucose and blood pressure levels in type 2 diabetes reduce the risk of developing cardiovascular autonomic neuropathy (CAN), a frequent but underdiagnosed ...

Intensive blood pressure control to a target of less than 120 mm Hg was not associated with a reduction of cerebral perfusion compared with a standard target of less than 140 mm Hg in a substudy of ...

We previously reported that a median of 5.6 years of intensive as compared with standard glucose lowering in 1791 military veterans with type 2 diabetes resulted in a risk of major cardiovascular ...

With all events adjudicated, intensive blood pressure-lowering remains superior to standard control when it comes to reducing adverse clinical outcomes in nondiabetic patients at high cardiovascular ...

Intensive glucose control has been suggested for critically ill patients to improve outcomes. Two recent reports, a systematic review and a new randomized trial, found this treatment was associated ...